Ondine’s Steriwave Shortlisted as Finalist for Prestigious 2025 Bionow Product of the Year Award Ondine Biomedical Inc. is proud to announce that its pioneering nasal photodisinfection technology, Steriwave, has been shortlisted as a finalist for the Product of the Year Award at the 2025 Bionow Awards. The Bionow Awards are [...]

Island Health’s New Regional Powerhouse, Cowichan District Hospital, Adopts Steriwave to Lead Vancouver Island in Surgical Innovation  Ondine Biomedical Inc. today announced that Cowichan District Hospital, a facility within the Island Health Authority in British Columbia, is adopting Steriwave® nasal photodisinfection as a standard component of pre-surgical protocols for its orthopedic patients [...]

Steriwave Expands into ENT Surgery in Spain Ondine Biomedical Inc. is pleased to announce the deployment of its Steriwave® nasal photodisinfection technology into a leading ear, nose and throat (ENT) specialist group operating surgical centres in Madrid and Málaga. Many ENT procedures involve operating in, or passing through, the nasal [...]

New Independent Study Supports Photodisinfection Ondine Biomedical Provides Biological Context for Nasal Decolonization Strategies Following Landmark Nasal Microbiome Study Ondine Biomedical Inc. (AIM: OBI), a leader in light-activated antimicrobial therapies, highlights new biological evidence supporting its photodisinfection technology in a newly published study in Nature Communications (Aggarwal et al., 2025). [...]